Applying multimodal pain management in primary care

October 15, 2026
Provided by AAFP partner
Person in a lab coat checks a medication package while reviewing information on a tablet in a pharmacy storage area.

Looking beyond a single analgesic

Family physicians help patients navigate acute pain management, including the selection and safe use of over-the-counter (OTC) medicines. Nonopioid therapies have an important role, with treatment selection guided by the pain condition, patient preferences, concurrent medications, and individual risks.1,2

Multimodal analgesia involves using treatments that work in different ways to manage pain. Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) may be used individually or together in selected settings.1–3 Their complementary mechanisms of action provide the rationale for combination treatment, and evidence for specific fixed-dose regimens can help inform how they're used in practice.4

Evaluating an OTC fixed-dose combination

Acetaminophen is believed to work quickly to reduce pain signals. Naproxen sodium, an NSAID, provides longer-lasting relief by targeting pain caused by inflammation. Combining them in a single dose delivers both fast onset and extended duration of pain relief.5,6

Tylenol® with Naproxen, which was FDA approved in July 2026, is an opioid-free pain reliever that brings these two complementary analgesics in an OTC fixed-dose formulation. Each tablet contains acetaminophen 325 mg and naproxen sodium 110 mg; the labeled two-tablet dose provides 650 mg and 220 mg, respectively.5

A fixed-dose combination combines two ingredients in a single product, providing a simple approach for clinicians to consider for appropriate patients. One product provides one set of labeled directions and warnings and one dosing schedule.5

Clinical evidence can also inform treatment selection. In a randomized, double-blind Phase III trial involving patients with post-operative dental pain, the fixed-dose combination demonstrated greater pain relief than acetaminophen 650 mg, naproxen sodium 220 mg, or placebo, as measured by mean time-weighted sum of pain intensity difference over 12 hours (SPID 0–12).4

Putting the evidence into practice

For family physicians, applying a multimodal approach means matching treatment to the patient and the level of pain. When considering an OTC fixed-dose combination, this includes assessing the suitability of both ingredients, reviewing other medicines for overlapping ingredients, and discussing labeled directions and warnings.5

Understanding the evidence for a combination and the role of each ingredient can help physicians guide patients toward informed OTC pain management decisions. The launch of Tylenol® with Naproxen expands and enhances pain relief options for both patients and their physicians to further meet evolving and complex pain needs. 

For further information, visit Tylenol Professional​, which offers a library of resources for healthcare professionals.

Tylenol® with Naproxen is a multimodal, nonopioid option that broadens OTC analgesic choice, delivering effective analgesia when used as directed. Always read and follow the drug facts label for complete information.5

  1. 1.

    Dowell D, et al. CDC clinical practice guideline for prescribing opioids for pain, United States–2022. MMWR Recomm Rep. 2022;71(3):1–95.

  2. 2.

    Qaseem A, et al. Nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults: a clinical guideline from the American College of Physicians and American Academy of Family Physicians. Ann Intern Med. 2020;173(9):739–748.

  3. 3.

    Carrasco-Labra A, et al. Evidence-based clinical practice guideline for the pharmacologic management of acute dental pain in adolescents, adults, and older adults. J Am Dent Assoc. 2024;155(2):102–117.e9.

  4. 4.

    Budnitz D, et al. Analgesic effectiveness of a new fixed-dose combination acetaminophen/naproxen sodium: a Phase 3 placebo-controlled, randomized, double-blind, factorial trial in postoperative dental pain. Poster P083. Presented at PAINWeek 2026.

  5. 5.

    Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium 110 mg) tablets. Drug Facts labeling. Kenvue Brands LLC; 2026.

    https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/219962Orig1s000Lbl.pdf​.

  6. 6.

    Aronoff DM, et al. New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther. 2006;79(1):9–19.

Disclaimer:
The posting of information and content on this page should not be considered an AAFP endorsement or recommendation of the partner or sponsor organization’s products, services, policies or procedures. The information and opinions expressed are those of partners and paid sponsors and do not necessarily reflect the views of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page. Any links on this page to third-party websites where goods and services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods or services.